Trial
NCT01440179
SAR3419 in Acute Lymphoblastic Leukemia
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sanofi
Collaborators
—
Condition
Acute Lymphocytic Leukaemia
Intervention
SAR3419
Why stopped
The study is stopped due to very modest activity compared to competitors
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-21